191 related articles for article (PubMed ID: 19203434)
21. Retroperitoneal lymph node dissection in patients with high risk testicular cancer.
Williams SB; McDermott DW; Dock W; Bahnson E; Berry AM; Steele GS; Richie JP
J Urol; 2009 May; 181(5):2097-101; discussion 2101-2. PubMed ID: 19286227
[TBL] [Abstract][Full Text] [Related]
22. A meta-analysis of the sensitivity of various neuropsychological tests used to detect chemotherapy-induced cognitive impairment in patients with breast cancer.
Jansen CE; Miaskowski CA; Dodd MJ; Dowling GA
Oncol Nurs Forum; 2007 Sep; 34(5):997-1005. PubMed ID: 17878128
[TBL] [Abstract][Full Text] [Related]
23. Cognitive impairment associated with chemotherapy for cancer: report of a workshop.
Tannock IF; Ahles TA; Ganz PA; Van Dam FS
J Clin Oncol; 2004 Jun; 22(11):2233-9. PubMed ID: 15169812
[TBL] [Abstract][Full Text] [Related]
24. The influence of priming and pre-existing knowledge of chemotherapy-associated cognitive complaints on the reporting of such complaints in breast cancer patients.
Schagen SB; Das E; van Dam FS
Psychooncology; 2009 Jun; 18(6):674-8. PubMed ID: 19021129
[TBL] [Abstract][Full Text] [Related]
25. Cognitive functions and elderly cancer patients receiving anticancer treatment: a prospective study.
Minisini AM; De Faccio S; Ermacora P; Andreetta C; Fantinel R; Balestrieri M; Piga A; Puglisi F
Crit Rev Oncol Hematol; 2008 Jul; 67(1):71-9. PubMed ID: 18394917
[TBL] [Abstract][Full Text] [Related]
26. Cognitive effects of chemotherapy and/or cranial irradiation in adults.
Welzel G; Steinvorth S; Wenz F
Strahlenther Onkol; 2005 Mar; 181(3):141-56. PubMed ID: 15756518
[TBL] [Abstract][Full Text] [Related]
27. Information about chemotherapy-associated cognitive problems contributes to cognitive problems in cancer patients.
Schagen SB; Das E; Vermeulen I
Psychooncology; 2012 Oct; 21(10):1132-5. PubMed ID: 21769988
[TBL] [Abstract][Full Text] [Related]
28. [Psychometric evaluation of a neuropsychological test battery measuring cognitive dysfunction in cancer patients--recommendations for a screening tool].
Scherwath A; Poppelreuter M; Weis J; Schulz-Kindermann F; Koch U; Mehnert A
Fortschr Neurol Psychiatr; 2008 Oct; 76(10):583-93. PubMed ID: 18833503
[TBL] [Abstract][Full Text] [Related]
29. The (mis)classification of chemo-fog--methodological inconsistencies in the investigation of cognitive impairment after chemotherapy.
Shilling V; Jenkins V; Trapala IS
Breast Cancer Res Treat; 2006 Jan; 95(2):125-9. PubMed ID: 16261398
[TBL] [Abstract][Full Text] [Related]
30. Does cognitive impairment after chemotherapy for breast cancer improve over time or does practice make perfect?
Schagen SB; van Dam FS
J Clin Oncol; 2006 Nov; 24(32):5170-1; author reply 5171-2. PubMed ID: 17093282
[No Abstract] [Full Text] [Related]
31. Cognitive function after chemotherapy in adults with solid tumours.
Vardy J; Tannock I
Crit Rev Oncol Hematol; 2007 Sep; 63(3):183-202. PubMed ID: 17678745
[TBL] [Abstract][Full Text] [Related]
32. Examining the effects of adjuvant chemotherapy on cognition and the impact of any cognitive impairment on quality of life in colorectal cancer patients: study protocol.
Dwek MR; Rixon L; Simon A; Hurt C; Newman S
BMC Psychol; 2015 Nov; 3():43. PubMed ID: 26612628
[TBL] [Abstract][Full Text] [Related]
33. Two different sides of 'chemobrain': determinants and nondeterminants of self-perceived cognitive dysfunction in a prospective, randomized, multicenter study.
Hermelink K; Küchenhoff H; Untch M; Bauerfeind I; Lux MP; Bühner M; Manitz J; Fensterer V; Münzel K
Psychooncology; 2010 Dec; 19(12):1321-8. PubMed ID: 20127909
[TBL] [Abstract][Full Text] [Related]
34. Cognitive function and quality of life after surgery for early breast cancer in North Jutland, Denmark.
Debess J; Riis JØ; Pedersen L; Ewertz M
Acta Oncol; 2009; 48(4):532-40. PubMed ID: 19096948
[TBL] [Abstract][Full Text] [Related]
35. Subjective complaints compared to the results of neuropsychological assessment in patients with epilepsy: The influence of comorbid depression.
Liik M; Vahter L; Gross-Paju K; Haldre S
Epilepsy Res; 2009 Apr; 84(2-3):194-200. PubMed ID: 19264450
[TBL] [Abstract][Full Text] [Related]
36. Long-Term Cognitive Functioning in Testicular Germ-Cell Tumor Survivors.
Chovanec M; Vasilkova L; Setteyova L; Obertova J; Palacka P; Rejlekova K; Sycova-Mila Z; Kalavska K; Svetlovska D; Cingelova S; Mladosievicova B; Mardiak J; Mego M
Oncologist; 2018 May; 23(5):617-623. PubMed ID: 29352051
[TBL] [Abstract][Full Text] [Related]
37. [Testicular cancer].
Oldenburg J; Lehne G; Fosså SD
Tidsskr Nor Laegeforen; 2008 Feb; 128(4):457-60. PubMed ID: 18274581
[TBL] [Abstract][Full Text] [Related]
38. Pilot testing of the computerized cognitive test Microcog in chemotherapy-treated older cancer patients.
Extermann M; Chen H; Booth-Jones M; Meyer J; Balducci L; Jacobsen P
Crit Rev Oncol Hematol; 2005 May; 54(2):137-43. PubMed ID: 15843096
[TBL] [Abstract][Full Text] [Related]
39. Cognitive adverse effects of chemotherapy in breast cancer patients.
Correa DD; Ahles TA
Curr Opin Support Palliat Care; 2007 Apr; 1(1):57-62. PubMed ID: 18660726
[TBL] [Abstract][Full Text] [Related]
40. Cognitive impairment in men with testicular cancer prior to adjuvant therapy.
Wefel JS; Vidrine DJ; Veramonti TL; Meyers CA; Marani SK; Hoekstra HJ; Hoekstra-Weebers JE; Shahani L; Gritz ER
Cancer; 2011 Jan; 117(1):190-6. PubMed ID: 20737560
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
